Globally the taste of chocolate has attracted large populations instead of being just a tasty treat for kids. Chocolates are considered the most popular and cherished products consumed by people of any age group. It is observed that people worldwide consume more than 3 billion tons of cocoa beans a year. The factor that also drives the popularity of chocolates is that it provides a sense of calm feeling. The main reason for this is, it releases dopamine, a feel-good neurotransmitter. A stress reducer that also helps in the improvement of the memory. With the increasing popularity of consuming chocolates, its plantations have increased in West Africa & South East Asia. Countries like Ghana, Nigeria, Brazil, Indonesia, etc., account for the world’s largest cocoa supply.
Ice Cream Market Is Predicted To Reach A Valuation Of $97,301 Million During Forecast Period
einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.
Opportunities in the Asia-Pacific Flavored Milk Market to 2025 - China Holds a Prominent Market Share - Press Release
digitaljournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitaljournal.com Daily Mail and Mail on Sunday newspapers.
Technavio Research: Global Cocoa Market to Grow by Over 600 Thousand MT during 2020-2024 | High Demand from the Confectionary Segment to Drive Growth | Technavio
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201215005961/en/
Technavio has announced its latest market research report titled Global Cocoa Market 2020-2024 (Graphic: Business Wire)
Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.
Get FREE Sample Report in Minutes!
The report on the cocoa market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
Japan’s development of COVID-19 vaccines is far behind that of global rivals.
With the general public unlikely to have access to Japan-made vaccines until 2022, industry sources say reasons include a failure by the nation to address problems such as a lack of consolidation within the pharmaceutical industry and the sheltering of relatively small Japanese firms from international competition.
This week the U.K. became the first Western country to begin inoculating its citizens with a commercially available COVID-19 vaccine. The same day, biotech startup AnGes Inc. Japan’s front-runner, which has teamed up with Takara Bio Inc. and Osaka University announced it had started a mid- to late-stage clinical trial of its DNA-based vaccine involving 500 healthy adults at eight facilities in the nation.